Rapid Test vs PCR

Direct answer: Rapid antigen tests give a result in minutes at the point of care but are less sensitive; PCR detects nucleic acid with higher sensitivity in a laboratory. Use rapid tests to screen fast and PCR to confirm.

Comparison table

	Rapid test (lateral flow)	PCR
Target	Antigen / antibody	Nucleic acid (RNA/DNA)
Time to result	10–30 min	Hours
Sensitivity	Lower	Higher
Setting	Point of care	Laboratory
Instrument	None (visual read)	Thermal cycler
Cost	Lower	Higher

What each method detects

Rapid test: a target protein (antigen) or the immune response (antibody) — visible line readout.
PCR: amplifies and detects pathogen genetic material — the reference standard for many infections.

Strengths

Rapid: fast, portable, instrument-free, low cost, easy to deploy in field and clinic.
PCR: highest sensitivity/specificity, detects low pathogen load, quantifiable.

Limitations

Rapid: lower sensitivity, window period, subjective visual reading.
PCR: lab infrastructure, trained staff, longer turnaround, higher cost.

False negative / positive considerations

Rapid false negative: low viral/antigen load, testing outside the window.
PCR false negative: sample degradation or collection error; false positives from contamination are rare but possible.

Confirmatory testing

Rapid tests are screening-grade; PCR is typically the confirmatory method when accuracy is critical.

Procurement considerations

Distributors often supply rapid tests for screening volume and partner with labs for PCR confirmation.

Which test to choose

Choose a rapid antigen test for fast, low-cost screening at the point of care; choose PCR when accuracy and confirmation are critical.

Scenario	Recommended
Point-of-care screening	Rapid test
Confirmation	PCR
Field / outbreak response	Rapid test
Low viral load	PCR

Sources: WHO/CDC point-of-care vs molecular testing guidance.

Last reviewed: 2026-09-12